Dr. Tamar Green is an Assistant Professor of Psychiatry & Behavioral Sciences at Stanford University, and a child psychiatrist who works primarily with children with neurodevelopmental disorders such as ADHD and autism as well as with children with known genetic conditions ("neurogenetic syndromes" such as Noonan syndrome and other Rasopathies, Turner syndrome, 22q11.2 deletion syndrome). Dr. Green gained her training as a child psychiatrist at Tel Aviv University in Israel. She has completed a postdoctoral research fellow in neuroscience at the Center for Interdisciplinary Brain Sciences Research at the Department of Psychiatry and Behavioral Sciences at Stanford University. Currently, Dr. Green is an Assistant Professor at the department.
Dr. Green's research focus is on human genetic models for neurodevelopmental disorders. One of the lab's interests is the Rasopathies, a collection of syndromes associated with genetic mutations affecting the Ras/MAPK pathway. These studies are directed at uncovering neural correlates associated with deficits in attention, memory, and social skills in this syndrome. Results for this ongoing research also have the potential to yield valuable new insights into the role of the Ras/MAPK pathway in brain development in general, and attention, memory, and social skills.
The Brain Imaging, Development, and Genetic (BRIDGE) Lab focuses on disorders associated with child development, such as attention deficits, hyperactivity, and autism spectrum disorders. They apply two unique approaches in their research. Initially, they take a "genetic first" approach studying children with known genetic conditions who present with attention problems, hyperactivity, and deficits in social cognition. This approach contrasts with traditional research focused on the genetic causes of developmental disorders. Second, they apply in-depth phenotyping of the child's brain, genes, and behavior using brain imaging, genetic testing, and behavioral assessment. Consequently, the BRIDGE lab aims to uncover biological principles of how genetic variation and its associated downstream pathways affect children's developmental disorders.
